P Cairns - Nature Reviews Cancer, 2007 - nature.com
DNA methylation is a common mechanism of inactivation of tumour-suppressor and other cancer genes in neoplastic cells. The advantages of gene methylation as a target for the …
G Aus, S Bergdahl, P Lodding, H Lilja, J Hugosson - European urology, 2007 - Elsevier
OBJECTIVES: Randomized controlled trials are currently conducted to assess whether the mortality from prostate cancer is reduced by early detection with the use of prostate-specific …
P Tenke, J Horti, P Balint, B Kovacs - Prostate Cancer, 2007 - Springer
Prostate cancer is a major healthcare problem worldwide, especially in the industrialized countries of the Western world. Prostate cancer has become the most common type of …
WG Nelson - Current opinion in urology, 2007 - journals.lww.com
The contributions of infection and inflammation to the early development of prostate cancer suggest prevention strategies featuring prevention or eradication of infection, amelioration of …
NV Desireddi, KA Roehl, S Loeb, X Yu, CR Griffin… - Urology, 2007 - Elsevier
OBJECTIVES: Since the initiation of prostate-specific antigen (PSA) screening, the progression-free survival (PFS) rates after radical prostatectomy have markedly improved …
K Taymoorian, A Thomas, T Slowinski… - Anticancer …, 2007 - ar.iiarjournals.org
The aim of this study was to determine the prostate cancer detection rate of targeted biopsy using contrast-enhanced ultrasound (US) in patients with elevated prostate specific antigen …
AE Pelzer, J Bektic, T Akkad, S Ongarello… - The Journal of …, 2007 - auajournals.org
Purpose: Since the implementation of widespread serum total prostate specific antigen based screening, the risk of prostate cancer over diagnosis has become a concern. We …
Prostate cancer is often a complex disease and one in which many aspects of the disease and the affected patient must be taken into consideration before decisions about diagnostic …
IAO Odeyemi, R Berges… - Journal of Medical …, 2007 - Taylor & Francis
This study aimed to compare the economic impact of 1-, 3-and 6-monthly preparations of leuprolide acetate, a luteinising hormone-releasing hormone agonist (LHRHa), in the …